Page last updated: 2024-08-25

5-hydroxymethylcytosine and Skin Neoplasms

5-hydroxymethylcytosine has been researched along with Skin Neoplasms in 20 studies

Research

Studies (20)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's17 (85.00)24.3611
2020's3 (15.00)2.80

Authors

AuthorsStudies
Boudra, R; Lian, CG; Ramsey, MR; Schmults, CD; Wang, D; Wells, M; Woappi, Y; Xu, S1
Balzer, BL; Frishberg, DP; Shon, W; Yagi, S1
Cavalcante, RG; D'Silva, NJ; de Medeiros, MC; Fernandez, EM; Figueroa, ME; Liu, S; Qin, T; Rozek, LS; Sartor, MA; Wolf, GT; Zarins, KR1
Li, X; Lian, CG; Liu, F; Liu, X; Qiu, L; Tu, P; Wang, Y; Xiao, C; Yi, S1
Andrews, CA; Chan, MP; Kahana, A; Rao, RC1
Bizet, M; Bonvin, E; Calonne, E; Fuks, F; Larue, L; Luciani, F; Marine, JC; Nittner, D; Petit, V; Putmans, P; Radaelli, E; Santagostino, SF; Singh, NK1
Balzer, BL; Essner, R; Frishberg, DP; Huynh, CAT; Shon, W; Siref, AB1
Becker, JC; Dreibigacker, M; Gambichler, T; Rüddel, I; Schmitt, K; Stockfleth, E1
Urso, C1
Gambichler, T; Sand, M; Skrygan, M1
Ashida, A; Hayashi, K; Kiniwa, Y; Koga, H; Ogawa, E; Okuyama, R; Takazawa, Y; Uchiyama, A; Uchiyama, R; Uhara, H1
Dresser, KA; Larson, AR; Lezcano, C; Lian, CG; Mihm, MC; Murphy, GF; Scolyer, RA; Shi, YG; Thompson, JF; Woda, BA; Yosufi, B; Zhan, Q1
Granter, SR; Guo, W; Laga, AC; Lee, JJ; Lian, CG; Murphy, GF; Saavedra, AP; Xu, S; Zhan, Q1
Mikoshiba, Y; Ogawa, E; Okuyama, R; Uchiyama, A; Uchiyama, R; Uhara, H1
Burghart, DR; De Souza, A; Kempf, W; Pfaltz, M; Tinguely, M1
Burns, KH; Rodić, N; Sharma, R; Taube, JM; Zampella, J1
Cook, M; Lee, JJ; Lian, CG; Mihm, MC; Murphy, GF; Wang, TJ; Xu, S; Zhan, Q1
Fraitag, S; Hohl, D; Pavlova, O1
Bamford, M; Joshi, K; Lawes, K; Moosa, F; Pringle, JH; Saldanha, G; Teo, KW1
Bresler, SC; Fletcher, CD; Frank, AH; Granter, SR; Hu, NR; Lee, JJ; Lian, CG; Mihm, MC; Murphy, GF; Saw, RP; Scolyer, RA; Vilain, RE; Xu, S1

Other Studies

20 other study(ies) available for 5-hydroxymethylcytosine and Skin Neoplasms

ArticleYear
Regulation of 5-Hydroxymethylcytosine by TET2 Contributes to Squamous Cell Carcinoma Tumorigenesis.
    The Journal of investigative dermatology, 2022, Volume: 142, Issue:5

    Topics: 5-Methylcytosine; Animals; Carcinoma, Squamous Cell; Cell Transformation, Neoplastic; Dioxygenases; DNA Methylation; DNA-Binding Proteins; Humans; Mice; Proto-Oncogene Proteins; Skin Neoplasms

2022
Epigenetic marker expression is of limited diagnostic utility in spitzoid melanocytic neoplasms.
    Journal of cutaneous pathology, 2020, Volume: 47, Issue:12

    Topics: 5-Methylcytosine; Biomarkers, Tumor; Diagnosis, Differential; Epigenesis, Genetic; Female; Humans; Male; Melanoma; Nevus, Epithelioid and Spindle Cell; Skin Neoplasms

2020
5-Hydroxymethylation highlights the heterogeneity in keratinization and cell junctions in head and neck cancers.
    Clinical epigenetics, 2020, 11-17, Volume: 12, Issue:1

    Topics: 5-Methylcytosine; Cell Movement; DNA Methylation; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Genome-Wide Association Study; Head and Neck Neoplasms; Humans; Intercellular Junctions; Keratinocytes; Male; Middle Aged; Papillomaviridae; Papillomavirus Infections; Skin Neoplasms; Squamous Cell Carcinoma of Head and Neck

2020
Loss of 5-Hydroxymethylcytosine Is an Epigenetic Biomarker in Cutaneous T-Cell Lymphoma.
    The Journal of investigative dermatology, 2018, Volume: 138, Issue:11

    Topics: 5-Methylcytosine; Apoptosis; Biomarkers, Tumor; Carcinogenesis; CD4-Positive T-Lymphocytes; Cell Line, Tumor; Disease Progression; Epigenesis, Genetic; Female; Humans; Keratinocytes; Lymphoma, T-Cell, Cutaneous; Male; Mycosis Fungoides; Neoplasm Staging; Prognosis; Skin Neoplasms; Survival Analysis

2018
Epigenetic markers in basal cell carcinoma: universal themes in oncogenesis and tumor stratification? - a short report.
    Cellular oncology (Dordrecht), 2018, Volume: 41, Issue:6

    Topics: 5-Methylcytosine; Carcinogenesis; Carcinoma, Basal Cell; Epigenesis, Genetic; Histones; Humans; Lysine; Methylation; Skin Neoplasms

2018
TET2-Dependent Hydroxymethylome Plasticity Reduces Melanoma Initiation and Progression.
    Cancer research, 2019, 02-01, Volume: 79, Issue:3

    Topics: 5-Methylcytosine; Animals; Dioxygenases; Disease Progression; DNA-Binding Proteins; DNA, Neoplasm; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Humans; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Knockout; Mice, Transgenic; Monomeric GTP-Binding Proteins; Proto-Oncogene Proteins; Rats; Skin Neoplasms

2019
Diagnostic utility of dual 5-hydroxymethylcytosine/Melan-A immunohistochemistry in differentiating nodal nevus from metastatic melanoma: An effective first-line test for the workup of sentinel lymph node specimen.
    Journal of cutaneous pathology, 2019, Volume: 46, Issue:4

    Topics: 5-Methylcytosine; Biomarkers, Tumor; Diagnosis, Differential; Humans; Immunohistochemistry; Lymphatic Metastasis; MART-1 Antigen; Melanoma; Melanoma, Cutaneous Malignant; Nevus, Pigmented; Sentinel Lymph Node; Sentinel Lymph Node Biopsy; Skin Neoplasms; Staining and Labeling

2019
Decreased 5-hydroxymethylcytosine immunoreactivity in primary Merkel cell carcinoma is a strong predictor for disease-specific death.
    The British journal of dermatology, 2019, Volume: 181, Issue:2

    Topics: 5-Methylcytosine; Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoma, Merkel Cell; Dioxygenases; DNA Methylation; DNA-Binding Proteins; Female; Follow-Up Studies; Humans; Immunohistochemistry; Isocitrate Dehydrogenase; Male; Merkel cell polyomavirus; Neoplasm Recurrence, Local; Neoplasm Staging; Pilot Projects; Prognosis; Proto-Oncogene Proteins; Sex Factors; Skin; Skin Neoplasms; Viral Load

2019
Certain and uncertain malignant potential in melanocytic skin neoplasms.
    Journal of cutaneous pathology, 2019, Volume: 46, Issue:9

    Topics: 5-Methylcytosine; Biomarkers; Humans; Nevus, Pigmented; Skin Neoplasms

2019
Loss of 5-hydroxymethylcytosine and ten-eleven translocation 2 protein expression in malignant melanoma.
    Melanoma research, 2013, Volume: 23, Issue:3

    Topics: 5-Methylcytosine; Biomarkers, Tumor; Cytosine; Dioxygenases; Disease Progression; DNA-Binding Proteins; Epigenomics; Humans; Melanoma; Paraffin Embedding; Proto-Oncogene Proteins; Skin Neoplasms; Translocation, Genetic

2013
5-Hydroxymethylcytosine as a useful marker to differentiate between malignant melanomas and benign melanocytic nevi.
    Journal of dermatological science, 2014, Volume: 73, Issue:2

    Topics: 5-Methylcytosine; Adult; Aged; Aged, 80 and over; Biomarkers; CpG Islands; Cytosine; DNA Methylation; Epigenesis, Genetic; Female; Humans; Keratinocytes; Male; Melanoma; Middle Aged; Nevus, Epithelioid and Spindle Cell; Nevus, Pigmented; Skin Neoplasms

2014
Loss of 5-hydroxymethylcytosine correlates with increasing morphologic dysplasia in melanocytic tumors.
    Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 2014, Volume: 27, Issue:7

    Topics: 5-Methylcytosine; Adult; Aged; Aged, 80 and over; Cytosine; DNA Methylation; Female; Humans; Male; Melanoma; Middle Aged; Nevus; Precancerous Conditions; Skin Neoplasms; Young Adult

2014
5-Hydroxymethylcytosine expression in metastatic melanoma versus nodal nevus in sentinel lymph node biopsies.
    Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 2015, Volume: 28, Issue:2

    Topics: 5-Methylcytosine; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Cytosine; Female; Fluorescent Antibody Technique; Humans; Immunohistochemistry; Lymph Nodes; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Nevus; Sentinel Lymph Node Biopsy; Skin Neoplasms

2015
5-Hydroxymethylcytosine is a useful marker to differentiate between dermatofibrosarcoma protuberans and dermatofibroma.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2016, Volume: 30, Issue:1

    Topics: 5-Methylcytosine; Biomarkers, Tumor; Cytosine; Dermatofibrosarcoma; Humans; Skin Neoplasms

2016
Loss of expression of 5-hydroxymethylcytosine in CD30-positive cutaneous lymphoproliferative disorders.
    Journal of cutaneous pathology, 2014, Volume: 41, Issue:12

    Topics: 5-Methylcytosine; Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Case-Control Studies; Child; Cytosine; Epigenesis, Genetic; Female; Humans; Immunohistochemistry; Ki-1 Antigen; Lymphoma, Primary Cutaneous Anaplastic Large Cell; Lymphomatoid Papulosis; Male; Middle Aged; Retrospective Studies; Skin Neoplasms; Young Adult

2014
Diagnostic utility of 5-hydroxymethylcytosine immunohistochemistry in melanocytic proliferations.
    Journal of cutaneous pathology, 2015, Volume: 42, Issue:11

    Topics: 5-Methylcytosine; Cytosine; Diagnosis, Differential; Humans; Immunohistochemistry; Lymph Nodes; Lymphatic Metastasis; Melanocytes; Melanoma; Nevus, Pigmented; Skin Neoplasms; Tissue Array Analysis

2015
Loss of the epigenetic mark, 5-Hydroxymethylcytosine, correlates with small cell/nevoid subpopulations and assists in microstaging of human melanoma.
    Oncotarget, 2015, Nov-10, Volume: 6, Issue:35

    Topics: 5-Methylcytosine; Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoma, Small Cell; Cytosine; Epigenomics; Female; Follow-Up Studies; Gene Expression Regulation, Neoplastic; Humans; Immunoenzyme Techniques; Male; Melanoma; Melanoma, Cutaneous Malignant; Middle Aged; Neoplasm Staging; Nevus, Pigmented; Prognosis; Skin Neoplasms; Young Adult

2015
5-Hydroxymethylcytosine Expression in Proliferative Nodules Arising within Congenital Nevi Allows Differentiation from Malignant Melanoma.
    The Journal of investigative dermatology, 2016, Volume: 136, Issue:12

    Topics: 5-Methylcytosine; Adult; Analysis of Variance; Biopsy, Needle; Cohort Studies; Diagnosis, Differential; Disease Progression; Dysplastic Nevus Syndrome; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Male; Melanoma; Melanoma, Cutaneous Malignant; Nevus, Pigmented; Real-Time Polymerase Chain Reaction; Reproducibility of Results; Retrospective Studies; Skin Neoplasms

2016
5-Hydroxymethylcytosine is an independent predictor of survival in malignant melanoma.
    Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 2017, Volume: 30, Issue:1

    Topics: 5-Methylcytosine; Age Factors; Aged; Female; Humans; Male; Melanoma; Middle Aged; Neoplasm Staging; Prognosis; Retrospective Studies; Skin; Skin Neoplasms; Survival Rate

2017
5-Hydroxymethylcytosine is a nuclear biomarker to assess biological potential in histologically ambiguous heavily pigmented melanocytic neoplasms.
    Journal of cutaneous pathology, 2017, Volume: 44, Issue:3

    Topics: 5-Methylcytosine; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Cohort Studies; Female; Fluorescent Antibody Technique; Humans; Immunohistochemistry; Male; Melanoma; Middle Aged; Nevus, Pigmented; Retrospective Studies; Skin Neoplasms; Young Adult

2017